Literature DB >> 19482089

Integrins as "functional hubs" in the regulation of pathological angiogenesis.

Liangru Contois1, Abebe Akalu, Peter C Brooks.   

Abstract

It is well accepted that complex biological processes such as angiogenesis are not controlled by a single family of molecules or individually isolated signaling pathways. In this regard, new insight into the interconnected mechanisms that regulate angiogenesis might be gained by examining this process from a more global network perspective. The coordination of signaling cues from both outside and inside many different cell types is required for the successful completion of angiogenesis. Evidence is accumulating that the multifunctional integrin family of cell adhesion receptors represent an important group of molecules that play active roles in sensing, integrating, and distributing a diverse set of signals that regulate many cellular events required for angiogenesis. Given the ability of integrins to bind numerous extracellular ligands and transmit signals in a bi-directional fashion, we will discuss the multiple ways by which integrins may serve as a functional hub during pathological angiogenesis. In addition, we will highlight potential imaging and therapeutic strategies based on the expanding new insight into integrin function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482089      PMCID: PMC2806796          DOI: 10.1016/j.semcancer.2009.05.002

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  165 in total

Review 1.  Biological impacts and context of network theory.

Authors:  Eivind Almaas
Journal:  J Exp Biol       Date:  2007-05       Impact factor: 3.312

2.  Cooperation between VEGF and beta3 integrin during cardiac vascular development.

Authors:  Sara M Weis; Jeffrey N Lindquist; Leo A Barnes; Kimberly M Lutu-Fuga; Jianhua Cui; Malcolm R Wood; David A Cheresh
Journal:  Blood       Date:  2006-10-24       Impact factor: 22.113

3.  Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.

Authors:  E Petitclerc; S Strömblad; T L von Schalscha; F Mitjans; J Piulats; A M Montgomery; D A Cheresh; P C Brooks
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

Review 4.  Assembly and signaling of adhesion complexes.

Authors:  Jorge L Sepulveda; Vasiliki Gkretsi; Chuanyue Wu
Journal:  Curr Top Dev Biol       Date:  2005       Impact factor: 4.897

5.  Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers.

Authors:  A Costanzo; M Talamonti; E Botti; G Spallone; M Papoutsaki; S Chimenti
Journal:  Dermatology       Date:  2009-04-16       Impact factor: 5.366

Review 6.  Multimodality imaging of tumor integrin alphavbeta3 expression.

Authors:  Xiaoyuan Chen
Journal:  Mini Rev Med Chem       Date:  2006-02       Impact factor: 3.862

7.  Requirement of vascular integrin alpha v beta 3 for angiogenesis.

Authors:  P C Brooks; R A Clark; D A Cheresh
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

8.  Integrin beta4 signaling promotes tumor angiogenesis.

Authors:  Sotiris N Nikolopoulos; Pamela Blaikie; Toshiaki Yoshioka; Wenjun Guo; Filippo G Giancotti
Journal:  Cancer Cell       Date:  2004-11       Impact factor: 31.743

9.  Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo.

Authors:  J Xu; D Rodriguez; E Petitclerc; J J Kim; M Hangai; Y S Moon; G E Davis; P C Brooks; S M Yuen
Journal:  J Cell Biol       Date:  2001-09-03       Impact factor: 10.539

10.  A cryptic fragment from fibronectin's III1 module localizes to lipid rafts and stimulates cell growth and contractility.

Authors:  Denise C Hocking; Katherine Kowalski
Journal:  J Cell Biol       Date:  2002-07-08       Impact factor: 10.539

View more
  19 in total

1.  The adaptor protein Shc integrates growth factor and ECM signaling during postnatal angiogenesis.

Authors:  Daniel Timothy Sweet; Zhongming Chen; David M Wiley; Victoria L Bautch; Ellie Tzima
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

2.  Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential.

Authors:  Radu Minea; Corey Helchowski; Barbara Rubino; Kyle Brodmann; Stephen Swenson; Francis Markland
Journal:  Toxicon       Date:  2011-02-24       Impact factor: 3.033

Review 3.  Role of the cytoskeleton in formation and maintenance of angiogenic sprouts.

Authors:  Kayla J Bayless; Greg A Johnson
Journal:  J Vasc Res       Date:  2011-04-04       Impact factor: 1.934

4.  The HU177 Collagen Epitope Controls Melanoma Cell Migration and Experimental Metastasis by a CDK5/YAP-Dependent Mechanism.

Authors:  Jennifer M Caron; XiangHua Han; Liangru Contois; Calvin P H Vary; Peter C Brooks
Journal:  Am J Pathol       Date:  2018-08-14       Impact factor: 4.307

Review 5.  Radiolabelled RGD peptides for imaging and therapy.

Authors:  F C Gaertner; H Kessler; H-J Wester; M Schwaiger; A J Beer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

Review 6.  Glycobiology of ocular angiogenesis.

Authors:  Anna I Markowska; Zhiyi Cao; Noorjahan Panjwani
Journal:  Glycobiology       Date:  2014-08-08       Impact factor: 4.313

7.  Importance of interaction between nerve growth factor and α9β1 integrin in glial tumor angiogenesis.

Authors:  Erin M Walsh; Richard Kim; Luis Del Valle; Michael Weaver; Joel Sheffield; Philip Lazarovici; Cezary Marcinkiewicz
Journal:  Neuro Oncol       Date:  2012-05-17       Impact factor: 12.300

8.  The β3-integrin binding protein β3-endonexin is a novel negative regulator of hypoxia-inducible factor-1.

Authors:  Damir Kračun; Florian Riess; Ivan Kanchev; Meinrad Gawaz; Agnes Görlach
Journal:  Antioxid Redox Signal       Date:  2014-03-13       Impact factor: 8.401

9.  Endorepellin affects angiogenesis by antagonizing diverse vascular endothelial growth factor receptor 2 (VEGFR2)-evoked signaling pathways: transcriptional repression of hypoxia-inducible factor 1α and VEGFA and concurrent inhibition of nuclear factor of activated T cell 1 (NFAT1) activation.

Authors:  Atul Goyal; Chiara Poluzzi; Chris D Willis; James Smythies; Adam Shellard; Thomas Neill; Renato V Iozzo
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

10.  Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities.

Authors:  Radu O Minea; Corey M Helchowski; Samuel J Zidovetzki; Fritz K Costa; Stephen D Swenson; Francis S Markland
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.